Red Light Holland Announces Filament Health's Largest-Ever Manufacturing Run of PEX010, the Standardized and Patented Natural Psilocybin Drug Candidate Trusted Across 80+ Studies Globally, Now Offering the Widest Standardized Dosing Range, from 0.5 mg to 25 mg
Toronto, Ontario--(Newsfile Corp. - July 8, 2026) -
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-07-08 8:00 AM EDT | Rhelion Life Sciences Corp.
Restart Life Sciences Details Next-Generation Product Pipeline and Segment Expansion for Holy Crap
Vancouver, British Columbia--(Newsfile Corp. - July 8, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide an update on its forward-looking product development and segment expansion roadmap for its wholly owned subsidiary, Holy Crap Foods Inc. Following the Company's recent disclosure of its preliminary June 2026 financial growth highlights, management is working to build upon this operational trajectory b
Technologies, Biotechnologies, Santé
2026-07-08 6:00 AM EDT | Restart Life Sciences Corp.
Defence Therapeutics Opens New Office in Hamilton to Expand Its Accum Radiopharmaceutical Platform
Montreal, Quebec--(Newsfile Corp. - July 8, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® technology, today announced the opening of a new office at McMaster Innovation Park in Hamilton, Ontario, supporting the Company's expanding radiopharmaceutical research and business development a
Biotechnologies, Pharmaceutique, Santé
2026-07-08 3:15 AM EDT | Defence Therapeutics Inc.
Adia Nutrition Inc. Enters FINRA Home Stretch for Corporate Name Change to Adia Med Inc.
Winter Park, Florida--(Newsfile Corp. - July 7, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) today announced it has entered the final stage of its corporate name change application from Adia Nutrition Inc. to Adia Med Inc. After several months of review by the Financial Industry Regulatory Authority (FINRA), including three rounds of comments and the submission of detailed supporting documentation, the Company believes it has now met all outstanding requirements. FINRA approval is anticipated wi
Soins de santé et hôpitaux, Santé
2026-07-07 10:19 AM EDT | Adia Med Inc.
Tersis Technologies Appoints Cynthia Maloney as Vice President of Strategic Grants & Public-Private Partnerships
Brooksville, Florida--(Newsfile Corp. - July 7, 2026) - Tersis Technologies, Inc. (OTCID: TERS), a clean technology company focused on transforming waste streams into valuable resources through advanced thermal conversion, carbon utilization, renewable energy, and sustainable infrastructure solutions, today announced the appointment of Cynthia Maloney as Vice President, Strategic Grants & Public-Private Partnerships.
Agriculture, Énergie, Énergies de substitution, Santé
2026-07-07 9:38 AM EDT | Tersis Technologies Inc.
ALST Health Brands Signs Memorandum of Understanding to Produce "Beyond the Game Network" Reality Soccer Series
Toronto, Ontario--(Newsfile Corp. - July 7, 2026) - ALST Health Brands (OTCID: ALST) today announced the execution of a Memorandum of Understanding (MOU) to develop and produce a new reality soccer series, "Beyond the Game Network." The agreement formalizes a strategic partnership to create original unscripted content that highlights player journeys, community impact, and the intersection of sport, health, and culture. Key elements of the MOU:
Soins de santé et hôpitaux, Commerce de détail, Santé
2026-07-07 8:16 AM EDT | AllStar Health Brands, Inc.
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Military Veterans PTSD Study at ARQ National Psychotrauma Centre
Toronto, Ontario--(Newsfile Corp. - July 7, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red Light", or the "Company") is an Ontario based organization advancing innovation and research within the legal psychedelic sector. Following its acquisition of Filament Health Corp. ("Filament"), the Company has expanded its pharmaceutical grade manufacturing, regulatory, and clinical research capabilities, supporting the advancement of naturally derived
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-07-07 8:12 AM EDT | Rhelion Life Sciences Corp.
Extendicare Announces Timing of 2026 Second Quarter Results and Conference Call
Markham, Ontario--(Newsfile Corp. - July 7, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced today that it plans to release its financial results for the second quarter of 2026 after market close on Thursday, August 6, 2026. A conference call hosted by Michael Guerriere, President and Chief Executive Officer and David Bacon, Executive Vice President and Chief Financial Officer, will be held on Friday, August 7, 2026, at 11:30 a.m. (EDT) to discuss the result
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-07-07 8:00 AM EDT | Extendicare Inc.
Apptly Strengthens Advisory Board with Appointment of Four Healthcare Leaders
Vancouver, British Columbia--(Newsfile Corp. - July 7, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL) (the "Company"), operator of the UberDoc direct-pay healthcare marketplace, today announced the appointment of Dr. Eric Bricker, Dr. Diana Girnita, Dr. Cristin Dickerson, and Dr. Fred Liss to its Advisory Board. The appointments bring extensive experience across healthcare finance, direct-pay specialty care, employer-sponsored healthcare, and physician leadershi
2026-07-07 8:00 AM EDT | Apptly Health Technologies Corp.
Promino Provides Mid-Year Corporate Update Highlighting Commercial Execution and Continued Growth of its Muscle Health Platform
Burlington, Ontario--(Newsfile Corp. - July 7, 2026) - Promino Nutritional Sciences Inc.
Aliments / boissons, Sports, Santé
2026-07-07 7:00 AM EDT | Promino Nutritional Sciences, Inc.
FendX Engages Technical Development and Design Expertise to Advance Its Surface Contamination Detection App Program
Vancouver, British Columbia--(Newsfile Corp. - July 7, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection solutions to reduce the spread of harmful pathogens, is pleased to announce that it has entered into two Statements of Work ("SOWs") dated July 6, 2026, to support the engineering and interface design of FendX's AI-driven surface contamination detection app using
Technologies, Soins de santé et hôpitaux, Santé
2026-07-07 7:00 AM EDT | FendX Technologies Inc.
Rapid Dose Therapeutics Extends Strategic Collaboration with Global Nicotine Leader and Initiating Saudi Arabia Commercialization
Burlington, Ontario--(Newsfile Corp. - July 7, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company specializing in oral thin film drug delivery technology, is pleased to announce the execution of a Memorandum of Understanding ("MOU") with a global leader in the nicotine products industry, extending the parties' ongoing collaboration surrounding RDT's proprietary QuickStrip™ dissolvable oral nicotine strip
2026-07-07 7:00 AM EDT | Rapid Dose Therapeutics Corp.
BetterLife Engages Nucro-Technics to Complete the last GLP Toxicology Study of BETR-001 Required by the FDA for IND and Phase 1
Vancouver, British Columbia--(Newsfile Corp. - July 6, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company") announces it has entered into an agreement with Nucro-Technics Inc. ("Nucro") to conduct the last IND-enabling GLP toxicology study with BETR-001 for its planned IND and Phase 1 program. BETR-001 is 2-bromo-lysergic acid diethylamide (2-Br-LSD), a non-hallucinogenic derivative of LSD. BETR-001 is a potent neuroplastogen an
2026-07-06 8:00 AM EDT | BetterLife Pharma Inc.
CBIH Announces Recognition Initiative Funded Through CEO's Personal Share Holdings
Houston, Texas--(Newsfile Corp. - July 6, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announces that Dante Picazo, Chief Executive Officer of the Company, has designated 500,000,000 shares of common stock from his personal holdings to honor the directors, employees, and key associates whose dedication, loyalty, and work have helped shape CBIH's journey and strengthen the Company through years
Biotechnologies, Pharmaceutique, Cannabis, Santé
2026-07-06 7:00 AM EDT | Cannabis Bioscience International Holdings
TempraMed Signs LOI for Exclusive Distribution in Kuwait, Expanding Presence in High-Growth Gulf Region Healthcare Market
Highlights TempraMed signs non-binding LOI for exclusive distribution in Kuwait with Elegir Trading Kuwait represents a high-value market with significant demand for insulin, GLP-1 therapies, biologics, and other temperature-sensitive medications LOI includes minimum annual purchase commitments in Year 1 Expands TempraMed's footprint across the Middle East and supports broa
Technologies, Biotechnologies, Pharmaceutique, Santé
2026-07-06 7:00 AM EDT | TempraMed Technologies Ltd.
Cheelcare Closes $3.02 Million Upsized Non-Brokered Private Placement
Markham, Ontario--(Newsfile Corp. - July 3, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, is pleased to announce that it has closed its previously announced upsized non-brokered private placement (the "Offering"), raising aggregate gross proceeds of $3,023,250. The Offering was increased from $1.5 million to $3.0 million in response to strong investor demand, as previously announced on June 16, 2026
2026-07-03 7:30 AM EDT | Cheelcare Inc.
Custom Health Delivers US$51.6 Million Proforma Annualized Revenue Run-Rate in Q1-2026
For the three months ended March 31, 2026, Custom Health achieved quarterly revenue of US$4.3 million, while InnovativeRx (as defined below) achieved record quarterly revenue of US$8.6 million, reflecting total consolidated quarterly revenue of US$12.9 million and proforma annualized revenue run-rate(1) of US$51.6 million. Custom Health successfully completed its public listing and started trading on the Toronto Stock Exchange on June 24,
Technologies, Pharmaceutique, Santé
2026-07-03 6:00 AM EDT | Custom Health Holdings Inc.
Modern Luxury Vegas Recognizes Dr. Christina Rahm Among Its 2026 Power Players
Las Vegas, Nevada--(Newsfile Corp. - July 2, 2026) - Dr. Christina Rahm, renowned scientist, entrepreneur, humanitarian and founder of DRC Ventures and ROOT Brands, was recognized as one of Modern Luxury Vegas' 2026 Power Players and joined fellow honorees at a celebration hosted by Modern Luxury Vegas on June 11. Held at Maroon, the invitation-only gathering brought together leaders featured in the publication's Power Players initiative, which highlights influential individuals shapin
Biotechnologies, Aliments / boissons, Santé
2026-07-02 4:32 PM EDT | DRC Ventures
Izotropic Executes Formal Agreement with Izotropic Africa for Exclusive Distribution Throughout Africa and the GCC
British Columbia and Casablanca, Morocco--(Newsfile Corp. - July 2, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT imaging system for the more accurate screening and diagnosis of breast cancers, announces that, further to its
2026-07-02 8:00 AM EDT | Izotropic Corporation
Delivra Health Brands Launches LivRelief (TM) Itch Relief Cream in the Canadian Market
Vancouver, British Columbia--(Newsfile Corp. - July 2, 2026) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that its LivReliefTM brand is launching its new Itch Relief Cream in the Canadian market. The LivRelief TM Itch Relief Cream is available to Company distributors, retailers and e-commer
Cannabis, Santé, Extracteurs de cannabis, Producteurs de cannabis
2026-07-02 7:30 AM EDT | Delivra Health Brands Inc.